Recurrent urinary tract infections in healthy and nonpregnant women

Urological Science

Volumn 25, Issue 1, 2014, Pages 1-8

  Glover, Matthew ^a   Moreira, Cristiano G ^a   Sperandio, Vanessa ^a   Zimmern, Philippe ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Intracellular bacterial communities; Postmenopausal women; Quiescent intracellular reservoir; Recurrent urinary tract infections; Reinfection; Risk factors for urinary tract infections

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; COTRIMOXAZOLE; ESTRIOL; ESTROGEN; NITROFURANTOIN; PLACEBO;

BACTERIAL STRAIN; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; INFECTION PREVENTION; NONHUMAN; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT INFECTION; RECURRENT URINARY TRACT INFECTION; REVIEW; RISK FACTOR; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84896543995     PISSN: 18795226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urols.2013.11.007     Document Type: Review

References (89)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl.1A):5S-13S.
2. Griebling T.L. Urologic diseases in America project: trends in resource use for urinary tract infections in women. JUrol 2005, 173:1281-1287.
3. Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000, 10:509-515.
4. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990, 80:331-333.
5. Mabeck C.E. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad Med J 1972, 48:69-75.
6. Ikäheimo R., Siitonen A., Heiskanen T., Kärkkäinen U., Kuosmanen P., Lipponen P., et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996, 22:91-99.
7. Stamm W.E., McKevitt M., Roberts P.L., White N.J. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991, 13:77-84.
8. Ejrnæs K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull 2011, 58:B4187.
9. Dason S., Dason J.T., Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J 2011, 5:316-322.
10. Scholes D., Hooton T.M., Roberts P.L., Stapleton A.E., Gupta K., Stamm W.E. Risk factors for recurrent urinary tract infection in young women. JInfect Dis 2000, 182:1177-1182.
11. Raz R. Postmenopausal women with recurrent UTI. Int J Antimicrob Agents 2001, 17:269-271.
12. Yilmaz A., Bahat E., Yilmaz G.G., Hasanoglu A., Akman S., Guven A.G. Adjuvant effect of vitamin A on recurrent lower urinary tract infections. Pediatr Int 2007, 49:310-313.
13. Grabe M., Bishop M.C., Bjerklund-Johansen T.E., Botto H., Çek M., Lobel B., et al. Guidelines on the management of urinary and male genital tract infections. Arnhem: European Association of Urology 2008.
14. Grimes C.L., Lukacz E.S. Urinary tract infections. Female Pelvic Med Reconstr Surg 2011, 17:272-278.
15. Damiano R., Quarto G., Bava I., Ucciero G., De Domenico R., Palumbo M.I., et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol 2011, 59:645-651.
16. Zhong Y.H., Fang Y., Zhou J.Z., Tang Y., Gong S.M., Ding X.Q. Effectiveness and safety of patient-initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study. JInt Med Res 2011, 39:2335-2343.
17. Nygaard I., Brubaker L., Chai T.C., Markland A.D., Menefee S.A., Sirls L., et al. Risk factors for urinary tract infection following incontinence surgery. Int Urogynecol J 2011, 22:1255-1265.
18. van der Starre W.E., van Nieuwkoop C., Paltansing S., van't Wout J.W., Groeneveld G.H., Becker M.J., et al. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. JAntimicrob Chemother 2011, 66:650-656.
19. Moreno E., Andreu A., Pérez T., Sabaté M., Johnson J.R., Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women andthe dominant faecal flora of the same hosts. Epidemiol Infect 2006, 134:1015-1023.
20. Hooton T.M. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001, 17:259-268.
21. Stamey T.A., Sexton C.C. The role of vaginal colonization with Enterobacteriaceae in recurrent urinary infections. JUrol 1975, 2:214-217.
22. Cass A.S., Ireland G.W. Antibacterial perineal washing for prevention of recurrent urinary tract infections. Urology 1985, 25:492-494.
23. Nord C.E., Kager L., Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984, 76:99-106.
24. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
25. Reigstad C.S., Hultgren S.J., Gordon J.I. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. JBiol Chem 2007, 282:21259-21267.
26. Garofalo C.K., Hooton T.M., Martin S.M., Stamm W.E., Palermo J.J., Gordon J.I., et al. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun 2007, 75:52-60.
27. Justice S.S., Lauer S.R., Hultgren S.J., Hunstad D.A. Maturation of intracellularEscherichia coli communities requires SurA. Infect Immun 2006, 74:4793-4800.
28. Anderson G.G., Goller C.C., Justice S., Hultgren S.J., Seed P.C. Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun 2010, 78:963-975.
29. Tenke P., Koves B., Nagy K., Hultgren S.J., Mendling W., Wullt B., et al. Update on biofilm infections in the urinary tract. World J Urol 2012, 30:51-57.
30. Rosen D.A., Hooton T.M., Stamm W.E., Humphrey P.A., Hultgren S.J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007, 4:e329.
31. Anderson G.G., Martin S.M., Hultgren S.J. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect 2004, 6:1094-1101.
32. Justice S.S., Hung C., Theriot J.A., Fletcher D.A., Anderson G.G., Footer M.J., et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 2004, 101:1333-1338.
33. Hannan T.J., Totsika M., Mansfield K.J., Moore K.H., Schembri M.A., Hultgren S.J. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 2012, 36:616-648.
34. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J., et al. Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli. Science 1998, 282:1494-1497.
35. Schwartz D.J., Chen S.L., Hultgren S.J., Seed P.C. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect Immun 2011, 79:4250-4259.
36. Mysorekar I.U., Hultgren S.J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 2006, 103:14170-14175.
37. Martinez J.J., Muvley M.A., Schilling J.D., Pinkner J.S., Hultgren S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 2000, 19:2803-2812.
38. Wolfe A.J., Toh E., Shibata N., Rong R., Kenton K., Fitzgerald M., et al. Evidence of uncultivated bacteria in the adult female bladder. JClin Microbiol 2012, 50:1376-1383.
39. Li B., Smith P., Horvath D.J., Romesberg F.E., Justice S.S. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect 2010, 12:662-668.
40. Jacobson S.H., Kühn I., Brauner A. Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring. Scand J Urol Nephrol 1992, 26:373-377.
41. Russo T.A., Stapleton A., Wenderoth S., Hooton T.M., Stamm W.E. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. JInfect Dis 1995, 2:440-445.
42. Ejrnaes K., Sandvang D., Lundgren B., Ferry S., Holm S., Monsen T., et al. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. JClin Microbiol 2006, 44:1776-1781.
43. Vosti K.L. Aprospective, longitudinal study of the behavior of serologically classified isolates of Escherichia coli in women with recurrent urinary tract infections. JInfect 2007, 55:8-18.
44. Skjøt-Rasmussen L., Hammerum A.M., Jakobsen L., Lester C.H., Larsen P., Frimodt-Møller N. Persisting clones of Escherichia coli isolates from recurrent urinary tract infection in men and women. JMed Microbiol 2011, 60:550-554.
45. Beerepoot M.A., den Heijer C.D., Penders J., Prins J.M., Stobberingh E.E., Geerlings S.E. Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clin Microbiol Infect 2012, 18:E84-E90.
46. Hooton T.M., Stapleton A.E., Roberts P.L., Winter C., Scholes D., Bavendam T., et al. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis 1999, 29:1600-1601.
47. Raz R., Gennesin Y., Wasser J., Stoler Z., Rosenfeld S., Rottensterich E., et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000, 30:152-156.
48. Raz R. Urinary tract infection in postmenopausal women. Korean J Urol 2011, 52:801-808.
49. Anand M., Wang C., French J., Isaacson-Schmid M., Wall L.L., Mysorekar I.U. Estrogen affects the glycosaminoglycan layer of the murine bladder. Female Pelvic Med Reconstr Surg 2012, 18:148-152.
50. Scholes D., Hawn T.R., Roberts P.L., Li S.S., Stapleton A.E., Zhao L.P., et al. Family history and risk of recurrent cystitis and pyelonephritis in women. JUrol 2010, 184:564-569.
51. Sheinfeld J., Schaeffer A.J., Cordon-Cardo C., Rogatko A., Fair W.R. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. NEngl J Med 1989, 320:773-777.
52. Kinane D.F., Blackwell C.C., Brettle R.P., Weir D.M., Winstanley F.P., Elton R.A. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) 1982, 285:7-9.
53. Smithson A., Sarrias M.R., Barcelo J., Suarez B., Horcajada J.P., Soto S.M., et al. Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. Clin Diagn Lab Immunol 2005, 12:1358-1363.
54. Frendéus B., Godaly G., Hang L., Karpman D., Lundstedt A.C., Svanborg C. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritisand may have a human counterpart. JExp Med 2000, 192:881-890.
55. Hawn T.R., Scholes D., Li S.S., Wang H., Yang Y., Roberts P.L., et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009, 4:e5990.
56. Foxman B., Gillespie B., Koopman J., Zhang L., Palin K., Tallman P., et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000, 151:1194-1205.
57. Mulvey M.A., Schilling J.D., Hultgren S.J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001, 69:4572-4579.
58. Mobley H.L., Green D.M., Trifillis A.L., Johnson D.E., Chippendale G.R., Lockatell C.V., et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 1990, 58:1281-1289.
59. Johnson J.R. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003, 17:261-278.
60. Ulett G.C., Totsika M., Schaale K., Carey A.J., Sweet M.J., Schembri M.A. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 2013, 16:1-8.
61. Wright K.J., Seed P.C., Hultgren S.J. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 2007, 9:2230-2241.
62. Mulvey M.A. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002, 4:257-271.
63. Andrews S.C., Robinson A.K., Rodríguez-Quinones F. Bacterial iron hemostasis. FEMS Microbiol Rev 2003, 27:215-237.
64. Henderson J.P., Crowley J.R., Pinkner J.S., Walker J.N., Tsukayama P., Stamm W.E., et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathogens 2009, 5:1-11.
65. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991, 4:80-128.
66. Dwyer P.L., O'Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol 2002, 14:537-543.
67. Albert X., Huertas I., Pereiró I., Sanfélix J., Gosalbes V., Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women (Review). Cochrane Database Syst Rev 2004, 3:CD001209.
68. Kraft J.K., Stamey T.A. The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) 1977, 56:55-60.
69. Stapleton A., Stamm W.E. Prevention of urinary tract infection. Infect Clin Dis North Am 1997, 11:719-733.
70. Lichtenberger P., Hooton T.M. Antimicrobial prophylaxis in women with recurrent urinary tract infections. Int J Antimicrob Agents 2011, 38:36-41.
71. Pfau A., Sacks T.G. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis 1992, 14:810-814.
72. Pfau A., Sacks T.G. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. JUrol 1994, 152:136-138.
73. Pfau A., Sacks T.G. Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin. JUrol 1989, 142:1276-1278.
74. Nicolle L.E., Harding G.K., Thompson M., Kennedy J., Urias B., Ronald A.R. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother 1989, 33:1032-1035.
75. Chew L.D., Fihn S.D. Recurrent cystitis in nonpregnant women. West J Med 1999, 170:274-277.
76. Melekos M.D., Asbach H.W., Gerharz E., Zarakovitis I.E., Weingaertner K., Naber K.G. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. JUrol 1997, 157:935-939.
77. Stapleton A., Latham R.H., Johnson C., Stamm W.E. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 1990, 264:703-706.
78. Raz R., Stamm W.E. Acontrolled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. NEngl J Med 1993, 329:753-756.
79. Eriksen B. Arandomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999, 5:1072-1079.
80. Perrotta C., Aznar M., Mejia R., Albert X., Ng C.W. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women (Review). Cochrane Database Syst Rev 2008, 2:CD005131.
81. Mierzwiak J., Murray S., Zimmern P. Favorable role of trigone fulguration in the management of recurrent urinary tract infections. Neurourol Urodynamics 2010, 29:304.
82. Barbosa-Cesnik C., Brown M.B., Buxton M., Zhang L., DeBusscher J., Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis 2011, 52:23-30.
83. Stapleton A.E., Dziura J., Hooton T.M., Cox M.E., Yarova-Yarovaya Y., Chen S., et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 2012, 87:143-150.
84. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2:123-140.
85. Watts R.E., Totsika M., Challinor V.L., Mabbett A.N., Ulett G.C., De Voss J.J., Schembri M.A. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria. Escherichia coli. Infect Immun 2012, 80:333-344.
86. Oelschlaeger T.A., Dobrindt U., Hacker J. Pathogenicity islands of uropathogenic E.coli and the evolution of virulence. Int J Antimicrob Agents 2002, 19:517-521.
87. Friedrich A.W., Köck R., Bielaszewska M., Zhang W., Karch H., Mathys W. Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humans. JClin Microbiol 2005, 43:546-550.
88. Zhao L., Gao S., Huan H., Xu X., Zhu X., Yang W., et al. Comparison of virulence factors and expression of specific genes between uropathogenic Escherichia coli and avian pathogenic E.coli in a murine urinary tract infection model and a chicken challenge model. Microbiology 2009, 155:1634-1644.
89. Raz R., Colodner R., Rohana Y., Battino S., Rottensterich E., Wasser I., et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003, 36:1362-1368.